Potential role of polymorphisms in the transporter genes ENT1 and MATE1/OCT2 in predicting TAS-102 efficacy and toxicity in patients with refractory metastatic colorectal cancer

M. Suenaga, M. Schirripa, S. Cao, W. Zhang, D. Yang, V. Dadduzio, L. Salvatore, B. Borelli, F. Pietrantonio, Y. Ning, S. Okazaki, M.D. Berger, Y. Miyamoto, R. Gopez, A. Barzi, T. Yamaguchi, F. Loupakis, H.-J. Lenz

Research output: Contribution to journalArticle

Cite this

Suenaga, M., Schirripa, M., Cao, S., Zhang, W., Yang, D., Dadduzio, V., Salvatore, L., Borelli, B., Pietrantonio, F., Ning, Y., Okazaki, S., Berger, M. D., Miyamoto, Y., Gopez, R., Barzi, A., Yamaguchi, T., Loupakis, F., & Lenz, H-J. (2017). Potential role of polymorphisms in the transporter genes ENT1 and MATE1/OCT2 in predicting TAS-102 efficacy and toxicity in patients with refractory metastatic colorectal cancer. European Journal of Cancer, 86, 197-206. https://doi.org/10.1016/j.ejca.2017.08.033